Furthermore, we identified a consistent C/EBPβ binding peak at the RCAN1-4 promoter in independent CUT&RUN data from breast cancer cells, indicating that this regulatory mechanism may be conserved in other cancers (Supplementary Fig. 4). This evidence concerns the gene CEBPB and breast carcinoma.